Search clinical trials for: Coppertone (BAY 987516)

Total 9037 results

New York State Psychiatric Institute
Bayer; National Institute on Aging (NIA)

Completed

Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172

Late Onset Alzheimer Disease

United States
University of New England
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

A Psychosocial Tele-health Stigma Intervention for Youth Living With HIV in Vietnam

Hiv | Stigma, Social

Vietnam
Shandong University

Unknown

Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection

Helicobacter Pylori | Eradication | Therapeutic Duration | Antimicrobial Susceptibility Test
Ain Shams University

Not yet recruiting

Evaluation of Marginal Bone Loss of Two Immediately Loaded Implants Retaining Mandibular Overdenture

Edentulous Alveolar Ridge

Egypt
University Hospital, Ghent

Completed

Measurement and Comparison of the Occlusive and Hydrating Capacity of Three Silicone Gels and One Gel Cream

Scar Tissue or Healthy Skin

Belgium
Georgetown University

Unknown

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease (AD)

Alzheimer's Disease

United States
Northwestern University
National Cancer Institute (NCI); Bayer

Completed

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Angiosarcoma

United States
University of Texas Southwestern Medical Center
Bayer

Withdrawn

Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma

Glioma | IDH Mutation
National Cancer Institute (NCI)

Completed

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Hilar Cholangiocarcinoma | Recurrent Gallbladder Carcinoma | Unresectable Extrahepatic Bile Duct Carcinoma | Unresectable Gallbladder Carcinoma | Gallbladder Adenocarcinoma | Recurrent Extrahepatic Bile Duct Carcinoma | Extrahepatic Bile Duct Adenocarcinoma | Gallbladder Adenocarcinoma With Squamous... and other conditions

United States
Bayer

Terminated

BAY1238097, First in Man

Neoplasms

United States, Switzerland, Germany, France, Finland, United Kingdom
Indiana University
Dreamland Baby Co.

Recruiting

Assessment of the Safety and Efficacy of Weighted Wearable Blankets in Healthy Infants During Sleep

Sleep

United States
Ain Shams University

Completed

Ventilatory Management of the Preterm Neonate in the Delivery Room

Respiratory Distress Syndrome, Newborn

Egypt
NRG Oncology
National Cancer Institute (NCI)

Completed

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Endometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Metastatic Endometrioid Adenocarcinoma

United States
Dana-Farber Cancer Institute
Bayer

Withdrawn

BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors

Solid Tumor

United States
Bayer

Completed

BAY 77-1931 Long-term Extension From Phase II Study

Hyperphosphatemia

Japan
University of Southern California
National Cancer Institute (NCI)

Completed

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

Gastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Pulmonary Carcinoid Tumor

United States
John Kirkwood
Bristol-Myers Squibb

Active, not recruiting

Nivolumab, BMS-936558 in Combination With Relatlimab, BMS-986016 in Patients With Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting

Melanoma

United States
Bayer

Completed

Prospective Multicenter Non-interventional Study in Patients With Knee or Hip Osteoarthritis Having a Theraflex Treatment

Osteoarthritis

Russian Federation
National Cancer Institute (NCI)

Active, not recruiting

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Ewing Sarcoma | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Refractory Ewing Sarcoma | Recurrent Alveolar Rhabdomyosarcoma | Refractory Alveolar Rhabdomyosarcoma

United States, Canada
Seoul National University Hospital

Completed

The Effects of Premeal Consumption of Protein-enriched Bar on Blood Glucose Level and Secretion of Hormones

Diabetes Mellitus

Korea, Republic of
Second Hospital of Jilin University

Unknown

Intersphincteric Resection With or Without Intraoperative Radiation in Rectal Cancer (IDAVON)

Rectal Cancer

China
Gilead Sciences

Completed

Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function

Inflammatory Disease

United States, New Zealand, Germany
Institute for Clinical and Experimental Medicine

Completed

Effect of Meal Frequency on Insulin Resistance in Subjects With Type 2 Diabetes (Frequency)

Diabetes Mellitus, Type 2

Czech Republic
Vanderbilt University Medical Center
4DMedical

Completed

4DX for the Diagnosis of Constrictive Bronchiolitis

Constrictive Bronchiolitis

United States
National Cancer Institute (NCI)

Completed

Sorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Stage IV Melanoma | Stage III Melanoma

United States
National Cancer Institute (NCI)

Terminated

Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional... and other conditions

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); Hanoi Medical University; The Friendship...

Completed

Friendship Bench Adaptation to Improve Mental Health & HIV Care Engagement Outcomes Among PLWH and PWID in Vietnam (VITAL)

Behavioral Symptoms | Depression | HIV Infections | Immune System Diseases | Anxiety | Opioid Dependence | Opioid-use Disorder | Virus Infection

Vietnam
Bayer

Terminated

Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Pharmacology, Clinical

Germany
University of California, San Francisco
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Reducing Pediatric Obesity Through After-school Programs

Obesity
Memorial Sloan Kettering Cancer Center
Bayer; State University of New York - Downstate Medical Center; Queens Cancer...

Active, not recruiting

Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma

Metastatic Colorectal Adenocarcinoma

United States
Bayer

Completed

Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjects

Prostatic Neoplasms

Japan
Yaakov Stern
National Institute on Aging (NIA)

Completed

Imaging of Cognition, Learning, and Memory in Aging

Alzheimer's Disease

United States
Samarkand State Medical Institute

Active, not recruiting

Verification of Kimmerle's Anomaly by X-ray Methods of Research

Kimmerle's Anomaly

Uzbekistan
Fermiscan Ltd

Unknown

Use of Hair to Diagnose the Presence of Breast Cancer

Breast Cancer

Australia
M.D. Anderson Cancer Center

Active, not recruiting

BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers

Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Carcinoma in the Liver | Metastatic Carcinoma in the Lung | Metastatic Malignant Neoplasm in the Thoracic Cavity

United States
Nanfang Hospital of Southern Medical University
Xiangya Hospital of Central South University; Peking University People's Hospital and other collaborators

Completed

Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML

Acute Myeloid Leukemia | Hematopoietic Stem Cell Transplantation | Acute Myeloid Leukemia With FLT3/ITD Mutation

China
Bayer

Completed

Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy (RECORA)

Colorectal Neoplasm

Germany
CStone Pharmaceuticals
Bayer

Completed

A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors

Advanced Refractory Solid Tumors

Australia
Nanfang Hospital of Southern Medical University

Recruiting

The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT

Allogeneic Hematopoietic Stem Cell Transplantation | Acute Myeloid Leukemia With FLT3/ITD Mutation

China
Nanfang Hospital of Southern Medical University

Recruiting

The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or Without Sorafenib Maintenance

Acute Leukemia | Allogeneic Hematopoietic Stem Cell Transplantation

China
Nanfang Hospital of Southern Medical University

Recruiting

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT

Allogeneic Hematopoietic Stem Cell Transplantation | Acute Myeloid Leukemia With FLT3/ITD Mutation

China
University Hospital, Toulouse

Completed

Postoperative Biliary Fistula Prevention After Hepatectomy

Hepatectomy

France
M.D. Anderson Cancer Center
Bayer; Xencor, Inc.

Withdrawn

Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)

Colorectal Cancer | Colon Cancer | Rectum Cancer

United States
IWK Health Centre
Dalhousie University

Recruiting

Single Patient Room Versus Open Bay in NICU

Neurodevelopmental Outcomes

Canada
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035) (VICTOR)

Chronic Heart Failure With Reduced Ejection Fraction

China, United States, Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czechia, Denmark, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Ireland, Israel, Italy, Korea, Republic of, Malaysia, Mexico, New Zealand, Peru and more
Bayer

Completed

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)

Diabetic Nephropathies

Japan
Bayer

Completed

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors (MATCHBOX)

Hemophilia A | Hemophilia B

South Africa, Poland, United Kingdom
Massachusetts General Hospital
American Cancer Society, Inc.

Terminated

Prevention of Delirium After Bone Marrow Transplantation

Delirium

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)

ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

United States
Bayer

Recruiting

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions (FINEROD)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

Germany, Japan

Search clinical trials for: Coppertone (BAY 987516)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations